Evidence map›Paper›PMID 25955256›Full record

ArticlePloS one2015

Production of transgenic-cloned pigs expressing large quantities of recombinant human lysozyme in milk.

Dan Lu, Shen Liu, Shengzhe Shang, Fangfang Wu, Xiao Wen, Zhiyuan Li, Yan Li, Xiaoxiang Hu, Yaofeng Zhao, Qiuyan Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Pig Genome Editing for Agriculture: Achievements and Challenges.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Review
  4. Transcriptome Atlas of 16 Donkey Tissues.Frontiers in genetics · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Dan LuThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Shen LiuThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Shengzhe ShangThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Fangfang WuCollege of Animal Science and Technology, Yunnan Agricultural University, Kunming, China.
Xiao WenBeijing Genfucare Biotechnology Company, Beijing, China.
Zhiyuan LiBeijing Genfucare Biotechnology Company, Beijing, China.
Yan LiBeijing Genfucare Biotechnology Company, Beijing, China.
Xiaoxiang HuThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Yaofeng ZhaoThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Qiuyan LiThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
Ning LiThe State Key Laboratory for Agro-biotechnology, China Agricultural University, Beijing, China.
China Agricultural University · CNYunnan Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human lysozyme is a natural non-specific immune factor in human milk that plays an important role in the defense of breastfed infants against pathogen infection. Although lysozyme is abundant in human milk, there is only trace quantities in pig milk. Here, we successfully generated transgenic cloned pigs with the expression vector pBAC-hLF-hLZ-Neo and their first generation hybrids (F1). The highest concentration of recombinant human lysozyme (rhLZ) with in vitro bioactivity was 2759.6 ± 265.0 mg/L in the milk of F0 sows. Compared with wild-type milk, rhLZ milk inhibited growth of Escherichia coli K88 during the exponential growth phase. Moreover, rhLZ in milk from transgenic sows was directly absorbed by the intestine of piglets with no observable anaphylactic reaction. Our strategy may provide a powerful tool for large-scale production of this important human protein in pigs to improve resistance to pathogen infection.

Indexed as

AnimalsAnimals, Genetically ModifiedCloning, OrganismEscherichia coliFemaleGene ExpressionHumansMilkMuramidaseRecombinant ProteinsSwineMuramidaseRecombinant Proteins

Identifiers

PMID25955256
PMCPMC4425539
OpenAlexW238298475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.